Tsutomu Nakagawa
Directeur/Bestuurslid bij SUMITOMO PHARMA CO., LTD.
Actieve functies van Tsutomu Nakagawa
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SUMITOMO PHARMA CO., LTD. | Directeur/Bestuurslid | 25-06-2024 | - |
| Corporate Officer/Principal | 01-04-2016 | - | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Directeur/Bestuurslid | 01-07-2023 | - |
| Algemeen Directeur | 01-04-2024 | - | |
| President | 01-04-2024 | - | |
| Corporate Officer/Principal | 01-07-2023 | 01-04-2024 |
Loopbaan van Tsutomu Nakagawa
Statistieken
Internationaal
| Verenigde Staten | 2 |
| Japan | 2 |
Operationeel
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Chief Executive Officer | 1 |
Sectoraal
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SUMITOMO PHARMA CO., LTD. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Health Technology |
- Beurs
- Insiders
- Tsutomu Nakagawa
- Ervaring
